Does clopidogrel use increase the prevalence of Parkinson's disease in US adults with diabetes?
Clopidogrel use is associated with an increased prevalence of Parkinson's disease in US adults, especially those with diabetes, suggesting a potential need for enhanced neurological monitoring in this population.
Antiplatelet drug use, particularly clopidogrel, is associated with increased PD prevalence, with this association being particularly pronounced in diabetic patients. However, as a cross-sectional analysis, this study cannot infer causality; furthermore, the medication-based definition of PD may involve diagnostic misclassification. Therefore, these findings should be interpreted with caution. Consideration could be given to enhanced monitoring of neurological symptoms for diabetic patients on long-term clopidogrel therapy. Prospective studies are needed to further explore potential mechanisms and temporal relationships.
Zhan et al. (Thu,) studied this question.